JP2019504102A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504102A5 JP2019504102A5 JP2018540796A JP2018540796A JP2019504102A5 JP 2019504102 A5 JP2019504102 A5 JP 2019504102A5 JP 2018540796 A JP2018540796 A JP 2018540796A JP 2018540796 A JP2018540796 A JP 2018540796A JP 2019504102 A5 JP2019504102 A5 JP 2019504102A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- methyl
- imidazo
- pharmaceutical composition
- propyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16154035.6 | 2016-02-03 | ||
| EP16154035 | 2016-02-03 | ||
| PCT/EP2017/052201 WO2017134133A1 (en) | 2016-02-03 | 2017-02-02 | Combination products for the treatment of rsv |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019504102A JP2019504102A (ja) | 2019-02-14 |
| JP2019504102A5 true JP2019504102A5 (https=) | 2020-03-12 |
| JP7065030B2 JP7065030B2 (ja) | 2022-05-11 |
Family
ID=55304886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018540796A Expired - Fee Related JP7065030B2 (ja) | 2016-02-03 | 2017-02-02 | Ｒｓｖの処置のための組合せ製品 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10363253B2 (https=) |
| EP (2) | EP3411028B1 (https=) |
| JP (1) | JP7065030B2 (https=) |
| KR (1) | KR20180108598A (https=) |
| CN (2) | CN112245429A (https=) |
| AU (2) | AU2017214246B2 (https=) |
| BR (1) | BR112018014958A2 (https=) |
| CA (1) | CA3006488A1 (https=) |
| CL (3) | CL2018001808A1 (https=) |
| EA (3) | EA202092250A1 (https=) |
| ES (1) | ES2877808T3 (https=) |
| IL (2) | IL259669B (https=) |
| MX (2) | MX381654B (https=) |
| MY (1) | MY197217A (https=) |
| PH (2) | PH12020551598B1 (https=) |
| SG (1) | SG11201806581TA (https=) |
| UA (1) | UA124099C2 (https=) |
| WO (1) | WO2017134133A1 (https=) |
| ZA (1) | ZA201805205B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017531039A (ja) | 2014-10-10 | 2017-10-19 | プルモシデ リミテド | 新規５，６−ジヒドロ−４Ｈ−ベンゾ［ｂ］チエノ−［２，３−ｄ］アゼピン誘導体 |
| JP6694886B2 (ja) | 2014-12-18 | 2020-05-20 | プルモシデ リミテド | ４，５−ジヒドロ−６Ｈ−チエノ［３，２−ｄ］ベンゾアゼピン誘導体及び呼吸器合胞体ウイルス（ＲＳＶ）感染を治療するためのその使用 |
| WO2017175000A1 (en) | 2016-04-08 | 2017-10-12 | Pulmocide Limited | Compounds |
| TW201936193A (zh) * | 2017-12-05 | 2019-09-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 使用組合產品治療ｒｓｖ |
| AU2020372633A1 (en) * | 2019-10-30 | 2022-04-21 | Janssen Sciences Ireland Unlimited Company | Synthesis of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2 yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one |
| CN114014856B (zh) * | 2021-11-26 | 2023-12-22 | 嘉兴安谛康生物科技有限公司 | 作为呼吸道合胞病毒抗病毒剂的咪唑并吡啶类衍生物 |
| CN116077494A (zh) * | 2023-01-11 | 2023-05-09 | 黑龙江中医药大学 | 一种治疗呼吸道合胞病毒的药物组合物及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI515187B (zh) | 2010-12-16 | 2016-01-01 | 健生科學愛爾蘭無限公司 | 作為呼吸道融合病毒抗病毒劑之吲哚類 |
| KR102236497B1 (ko) * | 2013-04-25 | 2021-04-06 | 얀센 백신스 앤드 프리벤션 비.브이. | 안정화된 가용성 예비융합 ｒｓｖ ｆ 폴리펩타이드 |
| AU2014308991B2 (en) | 2013-08-21 | 2019-02-14 | Janssen Biopharma, Inc. | Antiviral compounds |
| JP2017531039A (ja) * | 2014-10-10 | 2017-10-19 | プルモシデ リミテド | 新規５，６−ジヒドロ−４Ｈ−ベンゾ［ｂ］チエノ−［２，３−ｄ］アゼピン誘導体 |
-
2017
- 2017-02-02 EP EP17702125.0A patent/EP3411028B1/en active Active
- 2017-02-02 AU AU2017214246A patent/AU2017214246B2/en not_active Ceased
- 2017-02-02 BR BR112018014958-6A patent/BR112018014958A2/pt not_active Application Discontinuation
- 2017-02-02 SG SG11201806581TA patent/SG11201806581TA/en unknown
- 2017-02-02 JP JP2018540796A patent/JP7065030B2/ja not_active Expired - Fee Related
- 2017-02-02 UA UAA201809060A patent/UA124099C2/uk unknown
- 2017-02-02 CN CN202010988991.4A patent/CN112245429A/zh active Pending
- 2017-02-02 EA EA202092250A patent/EA202092250A1/ru unknown
- 2017-02-02 EA EA201891655A patent/EA037206B1/ru unknown
- 2017-02-02 KR KR1020187020776A patent/KR20180108598A/ko not_active Withdrawn
- 2017-02-02 MX MX2018009422A patent/MX381654B/es unknown
- 2017-02-02 CN CN201780009640.0A patent/CN108601774B/zh not_active Expired - Fee Related
- 2017-02-02 EA EA202092251A patent/EA202092251A1/ru unknown
- 2017-02-02 PH PH1/2020/551598A patent/PH12020551598B1/en unknown
- 2017-02-02 CA CA3006488A patent/CA3006488A1/en active Pending
- 2017-02-02 MY MYPI2018001388A patent/MY197217A/en unknown
- 2017-02-02 US US16/075,103 patent/US10363253B2/en active Active
- 2017-02-02 EP EP21170919.1A patent/EP3892273A3/en not_active Withdrawn
- 2017-02-02 ES ES17702125T patent/ES2877808T3/es active Active
- 2017-02-02 WO PCT/EP2017/052201 patent/WO2017134133A1/en not_active Ceased
- 2017-02-02 MX MX2020012592A patent/MX2020012592A/es unknown
-
2018
- 2018-05-29 IL IL259669A patent/IL259669B/en active IP Right Grant
- 2018-06-29 CL CL2018001808A patent/CL2018001808A1/es unknown
- 2018-08-02 ZA ZA2018/05205A patent/ZA201805205B/en unknown
- 2018-08-02 PH PH12018501649A patent/PH12018501649B1/en unknown
-
2019
- 2019-05-29 CL CL2019001455A patent/CL2019001455A1/es unknown
- 2019-05-29 CL CL2019001454A patent/CL2019001454A1/es unknown
-
2020
- 2020-09-10 IL IL277281A patent/IL277281B/en active IP Right Grant
-
2022
- 2022-03-25 AU AU2022202070A patent/AU2022202070A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019504102A5 (https=) | ||
| AU2015296322B2 (en) | 2-amino-pyrido[2,3-d]pyrimidin-7(8h)-one derivatives as CDK inhibitors and uses thereof | |
| PH12018501649A1 (en) | Combination products for the treatment of rsv | |
| TWI248932B (en) | Respiratory syncytial virus replication inhibitors | |
| AU2013345107B2 (en) | Heteroaromatic compounds as PI3 kinase modulators and methods of use | |
| JP2022527796A5 (https=) | ||
| JP2025535045A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質の複素環阻害剤及びその使用 | |
| TW201011021A (en) | Imidazopyridin-2-one derivative | |
| AU2014363894C1 (en) | Tropomyosin-related kinase (Trk) inhibitors | |
| EP3875078A1 (en) | Compounds for the treatment of covid-19 | |
| BR112019019555A2 (pt) | composto de fórmula i, composição farmacêutica, método de inibição de hpk1, método para melhorar uma resposta imune, método para tratar um distúrbio e uso do composto | |
| KR20180030199A (ko) | 콜로니 자극 인자-1 수용체(csf-1r) 저해제 | |
| JP2016538316A5 (https=) | ||
| JP2014513139A5 (https=) | ||
| JP6389829B2 (ja) | Ｐｉ３キナーゼモジュレータとしてのヘテロ芳香族化合物、及びその使用方法 | |
| JP2001097889A (ja) | Ｃｒｆアンタゴニストおよび関連組成物の使用 | |
| WO2018053189A2 (en) | Syk inhibitors | |
| JP2014503544A5 (https=) | ||
| TW200538128A (en) | Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists | |
| WO2022051568A1 (en) | Substituted 4-piperidinyl-pyrrolo[2,3-b]pyridines and related compounds and their use in treating medical conditions | |
| RU2019108259A (ru) | Комбинированная терапия для лечения гепатоцеллюлярной карциномы | |
| JP2016517877A5 (https=) | ||
| WO2011096490A1 (ja) | イミダゾピリジン－２－オン誘導体 | |
| JP2011178779A (ja) | イミダゾピリジン−２−オン誘導体 | |
| RU2022104462A (ru) | Фармацевтические соединения |